MARC

LEADER 00000nas a2200000 a 4500
001 ssj0000602875
003 WaSeSS
005 20200512172242.0
006 m d
007 cr n
008 110815c20119999nz u| p|s|||||| |0eng d
035 |a (WaSeSS)ssj0000602875 
040 |a WaSeSS  |c WaSeSS  |d WaSeSS 
050 4 |a QR185.8.A58 
245 0 0 |a Antibody technology journal  |h [electronic resource]. 
246 1 |a Journal of antibody technology journal 
260 |a Auckland, N.Z. :  |b Dove Medical Press 
362 1 |a Began with Vol. 1 (2011). 
506 |a License restrictions may limit access. 
588 |a Description based on: Vol. 1 (2011); title from title screen (Dovepress, viewed August 9, 2011). 
588 |a Latest issue consulted: Vol. 1 (2011) (August 9, 2011). 
650 0 |a Immunoglobulins  |x Therapeutic use  |v Periodicals. 
650 0 |a Monoclonal antibodies  |x Therapeutic use  |v Periodicals. 
655 0 |a Electronic journals. 
776 0 8 |i Print version:  |t Antibody technology journal  |x 2230-3170 
856 4 0 |z Full text available from Research Library: 01/01/2011 to 12/31/2012  |u https://search.proquest.com/publication/3933204 
856 4 0 |z Full text available from Research Library: 01/01/2014 to 01/31/2016  |u https://search.proquest.com/publication/3933204